Supplemental material Survival update of the OpACIN and OpACIN-neo trials

Published: 11 October 2024| Version 1 | DOI: 10.17632/35n6jyy23f.1
Contributor:
Judith Versluis

Description

Supplemental material Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trials

Files

Categories

Melanoma

Licence